Literature DB >> 4024000

Pulmonary platelet kinetics in asthma.

P W Ind, A M Peters, F Malik, J P Lavender, C T Dollery.   

Abstract

Platelets produce a range of bronchoconstrictor mediators. Measurements of plasma factors have implicated platelet activation in allergic asthma, and sensitised guinea pigs challenged with ovalbumin show pulmonary platelet aggregation accompanying bronchoconstriction. To investigate this further we injected autologous platelets labelled with indium 111 and red cells labelled with technetium 99m into three young volunteers with atopic asthma and three non-asthmatic volunteers and, after equilibration of platelets between blood and splenic pool, monitored lung 99mTc and 111In activities continuously. Comparison with the corresponding activities in blood samples allowed calculation of pulmonary platelet to red cell transit time ratio (tp/tr). This ratio was 0.9, 1.02, and 0.98 in the non-asthmatic subjects compared with 1.04, 0.97, and 1.17 in the asthmatic subjects. This argues against the existence of an intrapulmonary platelet pool in normal subjects; transpulmonary transit time was slightly prolonged in one asthmatic subject. Bronchial challenge with Dermatophagoides pteronyssinus was performed in the asthmatic subjects and monitoring continued for a further 30 minutes. Antigen induced falls in FEV1 of 20-50% were accompanied by small decreases in the 111In but not in the 99mTc lung signal. In line with this tp/tr fell to 0.89, 0.89, and 1.05. Antigen induced bronchoconstriction was therefore not accompanied by intrapulmonary platelet accumulation. Platelet survival was normal at 10.2 days in both groups of subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4024000      PMCID: PMC460089          DOI: 10.1136/thx.40.6.412

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

2.  Platelet activation and allergic asthma.

Authors:  P Gresele; T Todisco; F Merante; G G Nenci
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

3.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

4.  Thrombokinetics in man.

Authors:  L A Harker; C A Finch
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

5.  A simplified method of selective spleen scintigraphy with Tc-99m-labeled erythrocytes: clinical applications. Concise communication.

Authors:  R R Armas; M L Thakur; A Gottschalk
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

6.  Indium-111-labeled autologous platelets for location of vascular thrombi in humans.

Authors:  D A Goodwin; J T Bushberg; P W Doherty; M J Lipton; F K Conley; C I Diamanti; C F Meares
Journal:  J Nucl Med       Date:  1978-06       Impact factor: 10.057

7.  A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.

Authors:  A D Heyns; M G Lötter; H Pieters; F H Pauw; P N Badenhorst; P Wessels; P C Minnaar
Journal:  Clin Nephrol       Date:  1982-10       Impact factor: 0.975

8.  Lung transit of 111Indium-labelled granulocytes. Relationship to labelling techniques.

Authors:  S H Saverymuttu; A M Peters; H J Danpure; H J Reavy; S Osman; J P Lavender
Journal:  Scand J Haematol       Date:  1983-02

9.  Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.

Authors:  H H Davis; W A Heaton; B A Siegel; C J Mathias; J H Joist; L A Sherman; M J Welch
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

10.  Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity.

Authors:  M Goldman; H C Norcott; R J Hawker; C Hail; Z Drolc; C N McCollum
Journal:  Br J Surg       Date:  1982-07       Impact factor: 6.939

View more
  4 in total

1.  Platelet kinetics in asthmatic patients with and without aspirin intolerance.

Authors:  V Plaza; F Casals; A Alonso; C Picado
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

2.  The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.

Authors:  A J Coyle; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

Review 3.  An Insight into Recent Advances on Platelet Function in Health and Disease.

Authors:  Preeti Kumari Chaudhary; Sanggu Kim; Soochong Kim
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

4.  Platelet activation in nocturnal asthma.

Authors:  J F Morrison; S B Pearson; H G Dean; I R Craig; P N Bramley
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.